Discontinuation report COUMADIN TAB 4MG
Report ID | 28567 |
Drug Identification Number | 02007959 |
Brand name | COUMADIN TAB 4MG |
Common or Proper name | Warfarin |
Company Name | BRISTOL-MYERS SQUIBB CANADA |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | WARFARIN SODIUM |
Strength(s) | 4MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | Bottles of 250's only |
ATC code | B01AA |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-06-30 |
Actual discontinuation date | 2018-06-29 |
Remaining supply date | 2018-06-29 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | The bottles of 100's will continue to be available |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-11-07 | English | Compare |
v2 | 2017-11-07 | French | Compare |
v3 | 2018-07-27 | English | Compare |
v4 | 2018-07-27 | French | Compare |
Showing 1 to 4 of 4